# Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I

> **NCT01852890** · PHASE1 · COMPLETED · sponsor: **Joseph J. Cullen** · enrollment: 16 (actual)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **DRUG:** Ascorbate
- **DRUG:** Gemcitabine
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT01852890
- **Lead sponsor:** Joseph J. Cullen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2019-01-22
- **Final completion:** 2025-10-14
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-10-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852890, "Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01852890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*